Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review

Journal of Clinical Pharmacy and Therapeutics
Alicia K WatkinsJ N Brown

Abstract

Migraine is a common and costly neurological disorder that affects approximately 1 of every 7 people annually. Pharmacological therapy for prevention of migraine is warranted when patients experience at least 6 headache days, 4 headache days with at least some impairment or 3 headache days with severe impairment or requiring bed rest in a month. Levetiracetam is an antiepileptic drug that has the potential to be beneficial for migraine prophylaxis. The objective of this review was to assess the safety and efficacy of levetiracetam for migraine prophylaxis. A systematic search was conducted in MEDLINE (1946-August 2017), EMBASE (1947-August 2017) and CENTRAL using the terms: migraine disorders, migraine, or headache and etiracetam or levetiracetam. Animal studies, case reports, abstracts, letters to the editor and those not written in English were excluded. Eleven articles were identified for inclusion. Of the studies included, 2 were retrospective chart reviews, 4 were randomized placebo- or active comparator-controlled trials, and the remaining 5 were prospective, open-label studies. All studies found a statistically significant decrease in headache frequency per month compared to baseline or placebo when used for treatment of...Continue Reading

References

Apr 29, 1999·Archives of Internal Medicine·X H HuM L Berger
Jul 8, 2000·Epilepsia·R S Greenwood
Jan 15, 2003·Current Pain and Headache Reports·Jill Corbo
Aug 17, 2006·Acta Neurologica Scandinavica·J BauerD G A Kasteleijn-Nolst Trenité
Nov 11, 2006·Clinical Neuropharmacology·Filippo BrighinaBrigida Fierro
Mar 21, 2007·Headache·Ann PakalnisLisa Meier
Dec 12, 2007·Headache·Kevin HawkinsMarcia Rupnow
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Dec 17, 2009·Acta Neurologica Scandinavica·R KubaI Rektor
Jan 22, 2011·Central Nervous System Agents in Medicinal Chemistry·V PizzaA Capasso
Dec 14, 2011·Therapeutic Advances in Neurological Disorders·Clare M EddyAndrea E Cavanna
Jul 27, 2012·Lancet Neurology·Piero Perucca, Frank G Gilliam
Jun 19, 2013·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification Committee of the International Headache Society (IHS)
Jan 1, 2011·Journal of Central Nervous System Disease·Ginger C MintonBryan L Love
May 1, 2005·Current Therapeutic Research, Clinical and Experimental·Alan M RapoportMarcelo E Bigal

❮ Previous
Next ❯

Citations

Nov 27, 2019·European Journal of Clinical Pharmacology·Georgia TsaousiGeorgios Papazisis
Mar 19, 2019·Current Treatment Options in Neurology·Simy K Parikh, Stephen D Silberstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Megan E GeeEmily J A Young
© 2022 Meta ULC. All rights reserved